- CVS Health (CVS) Q4 results:
- Revenues: $66,889M (+22.9%); Pharmacy Services: $37,073M (+6.2%); Retail/LTC: $22,580M (+2.5%); Healthcare Benefits: $17,150M.
- Non-GAAP Operating Income: $3,766M (+1.3%); Net Income: $1,744M; EPS: $1.33; non-GAAP Net Income: $2,270M (-6.0%); non-GAAP EPS: $1.73 (-19.2%).
- CF Ops: $12,848M (+44.9%).
- Pharmacy claims processed: 533.9M (+10.2%).
- Pharmacy Services Generic dispensing rate of 87.8% vs. 86.9% in Q4 2018.
- Retail Prescription volume up 6.9%; Generic dispensing rate 87.5% vs. 86.7% a year ago.
- Medical membership 22.9M vs. 22.1M in Q4 2018.
-
2020 guidance: Operating income: $15.5B - 15.8B; EPS: $5.47 - 5.60; non-GAAP EPS: $7.04 - 7.17 vs. $7.15 S&P Capital IQ Consensus; cash flow ops: $10.5B - 11.0B.
- Shares are up 3% premarket.
- Previously: CVS Health EPS beats by $0.04, beats on revenue (Feb. 12)